Overview

A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This study will compare the cancer response to both treatments for locally advanced or metastatic breast cancer
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Genentech, Inc.
Treatments:
Albumin-Bound Paclitaxel
Bevacizumab
Gemcitabine
Paclitaxel